Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes
Authors:
- Athena Philis-TsimikasAPAthena Philis-Tsimikas
- Guillaume CharpentierGCGuillaume Charpentier
- Per ClausonPCPer Clauson
- Gabriela Martinez RavnGRGabriela Martinez Ravn
- Victor Lawrence RobertsVRVictor Lawrence Roberts
- Birger ThorsteinssonBTBirger Thorsteinsson
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (10) , 1569-1581
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 DiabetesDiabetes Care, 2006
- Once-daily Insulin Glargine Administration in the Morning Compared to Bedtime in Combination with Morning Glimepiride in Patients with Type 2 Diabetes: An Assessment of Treatment FlexibilityHormone and Metabolic Research, 2006
- Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 2006
- Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulinDiabetic Medicine, 2005
- Initiating Insulin Therapy in Type 2 DiabetesDiabetes Care, 2005
- Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapyClinical Therapeutics, 2004
- Comparison of the Subcutaneous Absorption of Insulin Glargine (Lantus®) and NPH Insulin in Patients with Type 2 DiabetesHormone and Metabolic Research, 2003
- Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patientsDiabetic Medicine, 2003
- A One-year, Randomised, Multicentre Trial Comparing Insulin Glargine with NPH Insulin in Combination with Oral Agents in Patients with Type 2 DiabetesHormone and Metabolic Research, 2003
- When oral agents fail: practical barriers to starting insulinInternational Journal of Obesity, 2002